Literature DB >> 23516690

RCPE UK consensus conference statement: Management of acute kidney injury: the role of fluids, e-alerts and biomarkers.

J Feehally, I Gilmore, S Barasi, M Bosomworth, B Christie, A Davies, J Dhesi, R Dowdle, C Gibbins, I Gonzalez, S Harding, D Lamont, G Murphy, M Ostermann, J Parr, P E Stevens.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23516690     DOI： 10.4997/JRCPE.2013.109

Source DB:  PubMed          Journal:  J R Coll Physicians Edinb        ISSN： 1478-2715


× No keyword cloud information.
  15 in total

1.  Acute kidney injury in the community: why primary care has an important role.

Authors:  Thomas Blakeman; Sarah Harding; Donal O'Donoghue
Journal:  Br J Gen Pract       Date:  2013-04       Impact factor: 5.386

2.  [Demonstration of tumor inhibiting properties of a strongly immunostimulating low-molecular weight substance. Comparative studies with ifosfamide on the immuno-labile DS carcinosarcoma. Stimulation of the autoimmune activity for approx. 20 days by BA 1, a N-(2-cyanoethylene)-urea. Novel prophylactic possibilities].

Authors:  M Ardenne; P G Reitnauer
Journal:  Arzneimittelforschung       Date:  1975-09

3.  Acute Kidney Injury in the Era of the AKI E-Alert.

Authors:  Jennifer Holmes; Timothy Rainer; John Geen; Gethin Roberts; Kate May; Nick Wilson; John D Williams; Aled O Phillips
Journal:  Clin J Am Soc Nephrol       Date:  2016-10-28       Impact factor: 8.237

Review 4.  Acute kidney injury in the ICU: from injury to recovery: reports from the 5th Paris International Conference.

Authors:  Rinaldo Bellomo; Claudio Ronco; Ravindra L Mehta; Pierre Asfar; Julie Boisramé-Helms; Michael Darmon; Jean-Luc Diehl; Jacques Duranteau; Eric A J Hoste; Joannes-Boyau Olivier; Matthieu Legrand; Nicolas Lerolle; Manu L N G Malbrain; Johan Mårtensson; Heleen M Oudemans-van Straaten; Jean-Jacques Parienti; Didier Payen; Sophie Perinel; Esther Peters; Peter Pickkers; Eric Rondeau; Miet Schetz; Christophe Vinsonneau; Julia Wendon; Ling Zhang; Pierre-François Laterre
Journal:  Ann Intensive Care       Date:  2017-05-04       Impact factor: 6.925

5.  Prescription of renin-angiotensin system blockers and risk of acute kidney injury: a population-based cohort study.

Authors:  Kathryn E Mansfield; Dorothea Nitsch; Liam Smeeth; Krishnan Bhaskaran; Laurie A Tomlinson
Journal:  BMJ Open       Date:  2016-12-21       Impact factor: 2.692

6.  The risks and benefits of patients temporarily discontinuing medications in the event of an intercurrent illness: a systematic review protocol.

Authors:  Andrew Morden; Jeremy Horwood; Penny Whiting; Jelena Savovic; Laurie Tomlinson; Thomas Blakeman; Charles Tomson; Alison Richards; Tracey Stone; Fergus Caskey
Journal:  Syst Rev       Date:  2015-10-24

Review 7.  Telephone based self-management support by 'lay health workers' and 'peer support workers' to prevent and manage vascular diseases: a systematic review and meta-analysis.

Authors:  Nicola Small; Christian Blickem; Tom Blakeman; Maria Panagioti; Carolyn A Chew-Graham; Peter Bower
Journal:  BMC Health Serv Res       Date:  2013-12-27       Impact factor: 2.655

Review 8.  Understanding the implementation of interventions to improve the management of chronic kidney disease in primary care: a rapid realist review.

Authors:  Jung Yin Tsang; Tom Blakeman; Janet Hegarty; John Humphreys; Gill Harvey
Journal:  Implement Sci       Date:  2016-04-04       Impact factor: 7.327

9.  Computerized clinical decision support for the early recognition and management of acute kidney injury: a qualitative evaluation of end-user experience.

Authors:  Nigel S Kanagasundaram; Mark T Bevan; Andrew J Sims; Andrew Heed; David A Price; Neil S Sheerin
Journal:  Clin Kidney J       Date:  2015-12-18

10.  Preventing Acute Kidney Injury: a qualitative study exploring 'sick day rules' implementation in primary care.

Authors:  Rebecca L Morris; Darren Ashcroft; Denham Phipps; Peter Bower; Donal O'Donoghue; Paul Roderick; Sarah Harding; Andrew Lewington; Thomas Blakeman
Journal:  BMC Fam Pract       Date:  2016-07-22       Impact factor: 2.497
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.